aluates Reports

$ 0.0

Automative

Global Intermediate CDMO Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-2Q13543

Global Intermediate CDMO Market Research Report 2023

BUY CHAPTERS

Global Intermediate CDMO Market Research Report 2025

Code: QYRE-Auto-2Q13543

Report

May 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pharmira

AGC

KriSan Biotech

SAURAV CHEMICALS

Olon Spa

AGC Biologics

Fermion

Pfizer CentreOne

Aspen Holdings

Hovione

Porton Pharma Solutions

Sinopep

Chongqing Huapont Pharmaceutical

Blue Jet Healthcare

Drug Discovery Alliances

Educell

Langhua Pharmaceutical

Intermediate CDMO Market

The global market for Intermediate CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Intermediate CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intermediate CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Intermediate CDMO in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Intermediate CDMO include Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances, KriSan Biotech, Saurav Chemicals, Olon SpA, AGC Biologics, Fermion, Pfizer CentreOne, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Intermediate CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intermediate CDMO.

The Intermediate CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intermediate CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intermediate CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Intermediate CDMO Market Report

Report Metric	Details
Report Name	Intermediate CDMO Market
Segment by Type	Antibiotic Intermediates Antipyretic and Analgesic Intermediate Cardiovascular System Drug Intermediates Anticancer Drug Intermediates
Segment by Application	Pharmaceutical Company Biotechnology Company Generic Company Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances, KriSan Biotech, Saurav Chemicals, Olon SpA, AGC Biologics, Fermion, Pfizer CentreOne, Aspen Holdings, Educell, Hovione, Porton Pharma Solutions, Sinopep, Chongqing Huapont Pharmaceutical, Langhua Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intermediate CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intermediate CDMO Market report?

Ans: The main players in the Intermediate CDMO Market are Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances, KriSan Biotech, Saurav Chemicals, Olon SpA, AGC Biologics, Fermion, Pfizer CentreOne, Aspen Holdings, Educell, Hovione, Porton Pharma Solutions, Sinopep, Chongqing Huapont Pharmaceutical, Langhua Pharmaceutical

What are the Application segmentation covered in the Intermediate CDMO Market report?

Ans: The Applications covered in the Intermediate CDMO Market report are Pharmaceutical Company, Biotechnology Company, Generic Company, Others

What are the Type segmentation covered in the Intermediate CDMO Market report?

Ans: The Types covered in the Intermediate CDMO Market report are Antibiotic Intermediates, Antipyretic and Analgesic Intermediate, Cardiovascular System Drug Intermediates, Anticancer Drug Intermediates

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Intermediate CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antibiotic Intermediates

1.2.3 Antipyretic and Analgesic Intermediate

1.2.4 Cardiovascular System Drug Intermediates

1.2.5 Anticancer Drug Intermediates

1.3 Market by Application

1.3.1 Global Intermediate CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Generic Company

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intermediate CDMO Market Perspective (2020-2031)

2.2 Global Intermediate CDMO Growth Trends by Region

2.2.1 Global Intermediate CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Intermediate CDMO Historic Market Size by Region (2020-2025)

2.2.3 Intermediate CDMO Forecasted Market Size by Region (2026-2031)

2.3 Intermediate CDMO Market Dynamics

2.3.1 Intermediate CDMO Industry Trends

2.3.2 Intermediate CDMO Market Drivers

2.3.3 Intermediate CDMO Market Challenges

2.3.4 Intermediate CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Intermediate CDMO Players by Revenue

3.1.1 Global Top Intermediate CDMO Players by Revenue (2020-2025)

3.1.2 Global Intermediate CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Intermediate CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Intermediate CDMO Revenue

3.4 Global Intermediate CDMO Market Concentration Ratio

3.4.1 Global Intermediate CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intermediate CDMO Revenue in 2024

3.5 Global Key Players of Intermediate CDMO Head office and Area Served

3.6 Global Key Players of Intermediate CDMO, Product and Application

3.7 Global Key Players of Intermediate CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Intermediate CDMO Breakdown Data by Type

4.1 Global Intermediate CDMO Historic Market Size by Type (2020-2025)

4.2 Global Intermediate CDMO Forecasted Market Size by Type (2026-2031)

5 Intermediate CDMO Breakdown Data by Application

5.1 Global Intermediate CDMO Historic Market Size by Application (2020-2025)

5.2 Global Intermediate CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Intermediate CDMO Market Size (2020-2031)

6.2 North America Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Intermediate CDMO Market Size by Country (2020-2025)

6.4 North America Intermediate CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Intermediate CDMO Market Size (2020-2031)

7.2 Europe Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Intermediate CDMO Market Size by Country (2020-2025)

7.4 Europe Intermediate CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Intermediate CDMO Market Size (2020-2031)

8.2 Asia-Pacific Intermediate CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Intermediate CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Intermediate CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Intermediate CDMO Market Size (2020-2031)

9.2 Latin America Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Intermediate CDMO Market Size by Country (2020-2025)

9.4 Latin America Intermediate CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Intermediate CDMO Market Size (2020-2031)

10.2 Middle East & Africa Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Intermediate CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Intermediate CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pharmira

11.1.1 Pharmira Company Details

11.1.2 Pharmira Business Overview

11.1.3 Pharmira Intermediate CDMO Introduction

11.1.4 Pharmira Revenue in Intermediate CDMO Business (2020-2025)

11.1.5 Pharmira Recent Development

11.2 AGC Inc

11.2.1 AGC Inc Company Details

11.2.2 AGC Inc Business Overview

11.2.3 AGC Inc Intermediate CDMO Introduction

11.2.4 AGC Inc Revenue in Intermediate CDMO Business (2020-2025)

11.2.5 AGC Inc Recent Development

11.3 Blue Jet Healthcare

11.3.1 Blue Jet Healthcare Company Details

11.3.2 Blue Jet Healthcare Business Overview

11.3.3 Blue Jet Healthcare Intermediate CDMO Introduction

11.3.4 Blue Jet Healthcare Revenue in Intermediate CDMO Business (2020-2025)

11.3.5 Blue Jet Healthcare Recent Development

11.4 Drug Discovery Alliances

11.4.1 Drug Discovery Alliances Company Details

11.4.2 Drug Discovery Alliances Business Overview

11.4.3 Drug Discovery Alliances Intermediate CDMO Introduction

11.4.4 Drug Discovery Alliances Revenue in Intermediate CDMO Business (2020-2025)

11.4.5 Drug Discovery Alliances Recent Development

11.5 KriSan Biotech

11.5.1 KriSan Biotech Company Details

11.5.2 KriSan Biotech Business Overview

11.5.3 KriSan Biotech Intermediate CDMO Introduction

11.5.4 KriSan Biotech Revenue in Intermediate CDMO Business (2020-2025)

11.5.5 KriSan Biotech Recent Development

11.6 Saurav Chemicals

11.6.1 Saurav Chemicals Company Details

11.6.2 Saurav Chemicals Business Overview

11.6.3 Saurav Chemicals Intermediate CDMO Introduction

11.6.4 Saurav Chemicals Revenue in Intermediate CDMO Business (2020-2025)

11.6.5 Saurav Chemicals Recent Development

11.7 Olon SpA

11.7.1 Olon SpA Company Details

11.7.2 Olon SpA Business Overview

11.7.3 Olon SpA Intermediate CDMO Introduction

11.7.4 Olon SpA Revenue in Intermediate CDMO Business (2020-2025)

11.7.5 Olon SpA Recent Development

11.8 AGC Biologics

11.8.1 AGC Biologics Company Details

11.8.2 AGC Biologics Business Overview

11.8.3 AGC Biologics Intermediate CDMO Introduction

11.8.4 AGC Biologics Revenue in Intermediate CDMO Business (2020-2025)

11.8.5 AGC Biologics Recent Development

11.9 Fermion

11.9.1 Fermion Company Details

11.9.2 Fermion Business Overview

11.9.3 Fermion Intermediate CDMO Introduction

11.9.4 Fermion Revenue in Intermediate CDMO Business (2020-2025)

11.9.5 Fermion Recent Development

11.10 Pfizer CentreOne

11.10.1 Pfizer CentreOne Company Details

11.10.2 Pfizer CentreOne Business Overview

11.10.3 Pfizer CentreOne Intermediate CDMO Introduction

11.10.4 Pfizer CentreOne Revenue in Intermediate CDMO Business (2020-2025)

11.10.5 Pfizer CentreOne Recent Development

11.11 Aspen Holdings

11.11.1 Aspen Holdings Company Details

11.11.2 Aspen Holdings Business Overview

11.11.3 Aspen Holdings Intermediate CDMO Introduction

11.11.4 Aspen Holdings Revenue in Intermediate CDMO Business (2020-2025)

11.11.5 Aspen Holdings Recent Development

11.12 Educell

11.12.1 Educell Company Details

11.12.2 Educell Business Overview

11.12.3 Educell Intermediate CDMO Introduction

11.12.4 Educell Revenue in Intermediate CDMO Business (2020-2025)

11.12.5 Educell Recent Development

11.13 Hovione

11.13.1 Hovione Company Details

11.13.2 Hovione Business Overview

11.13.3 Hovione Intermediate CDMO Introduction

11.13.4 Hovione Revenue in Intermediate CDMO Business (2020-2025)

11.13.5 Hovione Recent Development

11.14 Porton Pharma Solutions

11.14.1 Porton Pharma Solutions Company Details

11.14.2 Porton Pharma Solutions Business Overview

11.14.3 Porton Pharma Solutions Intermediate CDMO Introduction

11.14.4 Porton Pharma Solutions Revenue in Intermediate CDMO Business (2020-2025)

11.14.5 Porton Pharma Solutions Recent Development

11.15 Sinopep

11.15.1 Sinopep Company Details

11.15.2 Sinopep Business Overview

11.15.3 Sinopep Intermediate CDMO Introduction

11.15.4 Sinopep Revenue in Intermediate CDMO Business (2020-2025)

11.15.5 Sinopep Recent Development

11.16 Chongqing Huapont Pharmaceutical

11.16.1 Chongqing Huapont Pharmaceutical Company Details

11.16.2 Chongqing Huapont Pharmaceutical Business Overview

11.16.3 Chongqing Huapont Pharmaceutical Intermediate CDMO Introduction

11.16.4 Chongqing Huapont Pharmaceutical Revenue in Intermediate CDMO Business (2020-2025)

11.16.5 Chongqing Huapont Pharmaceutical Recent Development

11.17 Langhua Pharmaceutical

11.17.1 Langhua Pharmaceutical Company Details

11.17.2 Langhua Pharmaceutical Business Overview

11.17.3 Langhua Pharmaceutical Intermediate CDMO Introduction

11.17.4 Langhua Pharmaceutical Revenue in Intermediate CDMO Business (2020-2025)

11.17.5 Langhua Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pharmira

AGC

KriSan Biotech

SAURAV CHEMICALS

Olon Spa

AGC Biologics

Fermion

Pfizer CentreOne

Aspen Holdings

Hovione

Porton Pharma Solutions

Sinopep

Chongqing Huapont Pharmaceutical

Blue Jet Healthcare

Drug Discovery Alliances

Educell

Langhua Pharmaceutical

List of Tables

Table 1. Global Intermediate CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antibiotic Intermediates

Table 3. Key Players of Antipyretic and Analgesic Intermediate

Table 4. Key Players of Cardiovascular System Drug Intermediates

Table 5. Key Players of Anticancer Drug Intermediates

Table 6. Global Intermediate CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Intermediate CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Intermediate CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Intermediate CDMO Market Share by Region (2020-2025)

Table 10. Global Intermediate CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Intermediate CDMO Market Share by Region (2026-2031)

Table 12. Intermediate CDMO Market Trends

Table 13. Intermediate CDMO Market Drivers

Table 14. Intermediate CDMO Market Challenges

Table 15. Intermediate CDMO Market Restraints

Table 16. Global Intermediate CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Intermediate CDMO Market Share by Players (2020-2025)

Table 18. Global Top Intermediate CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intermediate CDMO as of 2024)

Table 19. Ranking of Global Top Intermediate CDMO Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Intermediate CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Intermediate CDMO, Headquarters and Area Served

Table 22. Global Key Players of Intermediate CDMO, Product and Application

Table 23. Global Key Players of Intermediate CDMO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Intermediate CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Intermediate CDMO Revenue Market Share by Type (2020-2025)

Table 27. Global Intermediate CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Intermediate CDMO Revenue Market Share by Type (2026-2031)

Table 29. Global Intermediate CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Intermediate CDMO Revenue Market Share by Application (2020-2025)

Table 31. Global Intermediate CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Intermediate CDMO Revenue Market Share by Application (2026-2031)

Table 33. North America Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Intermediate CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Intermediate CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Intermediate CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pharmira Company Details

Table 49. Pharmira Business Overview

Table 50. Pharmira Intermediate CDMO Product

Table 51. Pharmira Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 52. Pharmira Recent Development

Table 53. AGC Inc Company Details

Table 54. AGC Inc Business Overview

Table 55. AGC Inc Intermediate CDMO Product

Table 56. AGC Inc Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 57. AGC Inc Recent Development

Table 58. Blue Jet Healthcare Company Details

Table 59. Blue Jet Healthcare Business Overview

Table 60. Blue Jet Healthcare Intermediate CDMO Product

Table 61. Blue Jet Healthcare Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 62. Blue Jet Healthcare Recent Development

Table 63. Drug Discovery Alliances Company Details

Table 64. Drug Discovery Alliances Business Overview

Table 65. Drug Discovery Alliances Intermediate CDMO Product

Table 66. Drug Discovery Alliances Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 67. Drug Discovery Alliances Recent Development

Table 68. KriSan Biotech Company Details

Table 69. KriSan Biotech Business Overview

Table 70. KriSan Biotech Intermediate CDMO Product

Table 71. KriSan Biotech Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 72. KriSan Biotech Recent Development

Table 73. Saurav Chemicals Company Details

Table 74. Saurav Chemicals Business Overview

Table 75. Saurav Chemicals Intermediate CDMO Product

Table 76. Saurav Chemicals Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 77. Saurav Chemicals Recent Development

Table 78. Olon SpA Company Details

Table 79. Olon SpA Business Overview

Table 80. Olon SpA Intermediate CDMO Product

Table 81. Olon SpA Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 82. Olon SpA Recent Development

Table 83. AGC Biologics Company Details

Table 84. AGC Biologics Business Overview

Table 85. AGC Biologics Intermediate CDMO Product

Table 86. AGC Biologics Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 87. AGC Biologics Recent Development

Table 88. Fermion Company Details

Table 89. Fermion Business Overview

Table 90. Fermion Intermediate CDMO Product

Table 91. Fermion Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 92. Fermion Recent Development

Table 93. Pfizer CentreOne Company Details

Table 94. Pfizer CentreOne Business Overview

Table 95. Pfizer CentreOne Intermediate CDMO Product

Table 96. Pfizer CentreOne Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 97. Pfizer CentreOne Recent Development

Table 98. Aspen Holdings Company Details

Table 99. Aspen Holdings Business Overview

Table 100. Aspen Holdings Intermediate CDMO Product

Table 101. Aspen Holdings Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 102. Aspen Holdings Recent Development

Table 103. Educell Company Details

Table 104. Educell Business Overview

Table 105. Educell Intermediate CDMO Product

Table 106. Educell Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 107. Educell Recent Development

Table 108. Hovione Company Details

Table 109. Hovione Business Overview

Table 110. Hovione Intermediate CDMO Product

Table 111. Hovione Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 112. Hovione Recent Development

Table 113. Porton Pharma Solutions Company Details

Table 114. Porton Pharma Solutions Business Overview

Table 115. Porton Pharma Solutions Intermediate CDMO Product

Table 116. Porton Pharma Solutions Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 117. Porton Pharma Solutions Recent Development

Table 118. Sinopep Company Details

Table 119. Sinopep Business Overview

Table 120. Sinopep Intermediate CDMO Product

Table 121. Sinopep Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 122. Sinopep Recent Development

Table 123. Chongqing Huapont Pharmaceutical Company Details

Table 124. Chongqing Huapont Pharmaceutical Business Overview

Table 125. Chongqing Huapont Pharmaceutical Intermediate CDMO Product

Table 126. Chongqing Huapont Pharmaceutical Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 127. Chongqing Huapont Pharmaceutical Recent Development

Table 128. Langhua Pharmaceutical Company Details

Table 129. Langhua Pharmaceutical Business Overview

Table 130. Langhua Pharmaceutical Intermediate CDMO Product

Table 131. Langhua Pharmaceutical Revenue in Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 132. Langhua Pharmaceutical Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Intermediate CDMO Picture

Figure 2. Global Intermediate CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intermediate CDMO Market Share by Type: 2024 VS 2031

Figure 4. Antibiotic Intermediates Features

Figure 5. Antipyretic and Analgesic Intermediate Features

Figure 6. Cardiovascular System Drug Intermediates Features

Figure 7. Anticancer Drug Intermediates Features

Figure 8. Global Intermediate CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Intermediate CDMO Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Company Case Studies

Figure 11. Biotechnology Company Case Studies

Figure 12. Generic Company Case Studies

Figure 13. Others Case Studies

Figure 14. Intermediate CDMO Report Years Considered

Figure 15. Global Intermediate CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Intermediate CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Intermediate CDMO Market Share by Region: 2024 VS 2031

Figure 18. Global Intermediate CDMO Market Share by Players in 2024

Figure 19. Global Top Intermediate CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intermediate CDMO as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Intermediate CDMO Revenue in 2024

Figure 21. North America Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Intermediate CDMO Market Share by Country (2020-2031)

Figure 23. United States Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Intermediate CDMO Market Share by Country (2020-2031)

Figure 27. Germany Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Intermediate CDMO Market Share by Region (2020-2031)

Figure 35. China Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Intermediate CDMO Market Share by Country (2020-2031)

Figure 43. Mexico Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Intermediate CDMO Market Share by Country (2020-2031)

Figure 47. Turkey Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pharmira Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 51. AGC Inc Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 52. Blue Jet Healthcare Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 53. Drug Discovery Alliances Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 54. KriSan Biotech Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 55. Saurav Chemicals Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 56. Olon SpA Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 57. AGC Biologics Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 58. Fermion Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 59. Pfizer CentreOne Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 60. Aspen Holdings Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 61. Educell Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 62. Hovione Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 63. Porton Pharma Solutions Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 64. Sinopep Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 65. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 66. Langhua Pharmaceutical Revenue Growth Rate in Intermediate CDMO Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Small Molecule CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Softgel CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule Innovator CDMO Market Research Report 2025

Global Innovative Drug CDMO Market Research Report 2024

Global Microbial CDMO Service Market Research Report 2024

Global Mammalian CDMO Service Market Research Report 2024

Global Cell Therapy CDMO Market Research Report 2025

Global Chemical API CDMO Market Research Report 2024

DC Intermediate Relay Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell and Gene Therapy CDMO Market Research Report 2024

Packaging CDMO Market

Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plasmid CDMO Services Market Research Report 2025

Global Exosome CDMO Market Research Report 2024

Global CMO and CDMO biotechnology Market Research Report 2024

TV ODM Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Cell Therapy CDMO Market Research Report 2024

Audio Manager Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global BYOD Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11T6229

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Z5964

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11S6221

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Point of Sale Automation System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11J6299

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions